Grifols Sa Asset Turnover Ratio (GRFS), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Grifols Sa  (NASDAQ: GRFS)
 

Grifols Sa Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Grifols Sa asset turnover ratio, the ability of Grifols Sa's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.38 in the fourth quarter (Dec 31 2025), a new company high.

Within sector 117 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 2816.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GRFS Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -7.91 % -7.91 % -7.91 % -7.91 % -0.17 %
Y / Y Revenue Change 4.32 % - - - -
Asset Turnover Ratio (TTM) 0.38 - - - 0.34
GRFS's Total Ranking # 2816 # 0 # # #
Seq. Asset Change 0 % 0 % 0 % -7.91 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 118
Healthcare Sector # 386
Overall Market # 2816

Asset Turnover Ratio Statistics
High Average Low
0.38 0.36 0.34
(Dec 31 2025)   (Dec 31 2024)




GRFS Company Profile • Back to GRFS Efficiency Comparisons • Compare GRFS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Premier Air Charter Holdings Inc   1.05 $ 31.878  Millions$ 30.459  Millions
Rigel Pharmaceuticals Inc  1.03 $ 294.282  Millions$ 284.709  Millions
Regen Biopharma Inc   1.03 $ 0.237  Millions$ 0.229  Millions
Spero Therapeutics Inc   1.02 $ 66.802  Millions$ 65.729  Millions
Quipt Home Medical Corp   1.01 $ 264.974  Millions$ 261.171  Millions
Biodesix Inc   1.01 $ 88.499  Millions$ 87.545  Millions
Milestone Scientific Inc   1.01 $ 8.408  Millions$ 8.358  Millions
Nrc Health  1.00 $ 137.390  Millions$ 136.790  Millions
National Vision Holdings Inc   1.00 $ 1,987.488  Millions$ 1,980.214  Millions
Arcutis Biotherapeutics Inc   1.00 $ 376.072  Millions$ 375.122  Millions
Addus Homecare Corp  1.00 $ 1,421.874  Millions$ 1,419.190  Millions
Nexgel Inc   1.00 $ 10.509  Millions$ 10.557  Millions
Ensign Group Inc  0.99 $ 5,057.841  Millions$ 5,094.886  Millions
Omada Health Inc   0.99 $ 259.186  Millions$ 261.685  Millions
Kiniksa Pharmaceuticals International Plc  0.99 $ 677.564  Millions$ 684.111  Millions
Axsome Therapeutics Inc   0.98 $ 638.496  Millions$ 648.878  Millions
Orthofix Medical Inc   0.98 $ 822.017  Millions$ 835.890  Millions
National Healthcare Corp  0.98 $ 1,517.781  Millions$ 1,552.401  Millions
Ensysce Biosciences Inc   0.97 $ 5.067  Millions$ 5.205  Millions
Alphatec Holdings Inc   0.97 $ 763.888  Millions$ 788.556  Millions
Embecta Corp   0.97 $ 1,079.400  Millions$ 1,114.825  Millions
Argenx Se  0.97 $ 8,399.366  Millions$ 8,682.698  Millions
Cerus Corporation  0.96 $ 205.288  Millions$ 214.223  Millions
Fortrea Holdings Inc   0.95 $ 2,723.400  Millions$ 2,853.500  Millions
Pacs Group Inc   0.95 $ 5,288.932  Millions$ 5,551.874  Millions
Select Medical Holdings Corp  0.95 $ 5,452.830  Millions$ 5,743.891  Millions
Neuroone Medical Technologies Corp  0.95 $ 8.716  Millions$ 9.212  Millions
Strata Skin Sciences Inc  0.93 $ 29.429  Millions$ 31.556  Millions
Ufp Technologies Inc   0.93 $ 602.410  Millions$ 646.300  Millions
Accuray Incorporated  0.93 $ 436.226  Millions$ 470.396  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.